|
|
|
Pharmacogenomics -
Genetic Drug Response |
| |
Pharmacogenomics:
New Technologies in the Development of Personalized Therapies
Other Topics: Telemedicine
Terminals, Bioinformatics
Market 2007
IT Market Research
July 25, 2006
Pharmacogenomics, the science of genetic inheritance of an
individual’s response to drugs, is being increasingly applied at
the clinical level. The pharmacogenomics market is expected to
reach $4Bn by 2009
The term ‘Pharmacogenomics’ is evolved from the words –
pharmacology and genomics and therefore a combination of
pharmaceuticals and genetics. Pharmacogenomics is a specialized
study of how the genetic inheritance of an individual affects
his body’s response to drugs. Being increasingly applied at the
clinical level, its application is aimed on specific genes for
therapeutics, and on screening genes for potential drug uses. It
also aids pharmaceuticals in the development of highly
sophisticated medications. |
| |
|
|
| |
The application
of pharmacogenomics is based on the combination of traditional
pharmaceutical sciences such as biochemistry along with
knowledge of genes, proteins, and single nucleotide
polymorphisms. The present Pharmacogenomics market is comprised
of three central segments, which are projected with a high
growth rate. These are SNP identification technologies,
genotyping technologies, and diagnostics.
The thrust of pharmacogenomics depends on the genome-wide
analysis of the genetic characteristics of drug toxity and drug
efficacy. This is a challenge to the ability to identify genetic
variations also called polymorphisms that change a person’s
reaction to a drug.
RNCOS in its market research report, “Bioinformatics Market
Update (2006)” presents a compact analysis with respect to the
current market for pharmacogenomics and its future propensity.
Presently there has not been enough penetration in this area,
thus leaving enormous scope for research and growth. This
research report on Bioinformatics industry indicates particular
interest in the markets for SNP Identification technologies,
Genotyping technologies, and Diagnostics. Another area of
interest is the market for selected drugs aided by the use of
pharmacogenomics.
The report also states that the global bioinformatics market for
pharmacogenomics reached $1.25Bn in 2004 and is estimated to
jump to $4Bn by 2009 with an AAGR of 25%.
The report provides answers for some critical questions relating
to –
- The current global outlook
of Bioinformatics market;
- The recent developments in
the Bioinformatics industry;
- The worldwide growth of the
Genomics market;
- The driving forces of the
Bioinformatics market;
- The opportunities for growth
and impending threats for the industry; and
- Comparison between different
companies in the Bioinformatics market.
The report is a useful guide
for the pharmaceutical companies, IT firms, biotechnology firms,
prospective investors, students and academicians in the field of
bioinformatics.
About RNCOS
RNCOS, incorporated in 2002, provides Market Research Reports
for your business needs and aims to put an end to your
information pursuit. Our expertise in gathering global business
information for industry research, corporate training, growth
consulting, and business consulting, brings reputed companies
and firms to us for business enhancement solutions. We can be
your one-stop-shop for Industry research information and niche
market analysis
To purchase your copy: http://www.rncos.com/Report/IM045.htm
For more information about the report please visit www.rncos.com |
| |
|
|
| |
|
|
